Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Previously treated tuberculosis"'
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 32, Iss , Pp 100375- (2023)
Rationale: In 2017, the treatment regimen for previously treated persons with tuberculosis (TB) changed to a shorter regimen that lasts six months and consists of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol. Few studies have examined treatmen
Externí odkaz:
https://doaj.org/article/295d8866c188408bbbe96281a7f0fe03
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 19, Iss , Pp - (2020)
Rationale: Previously treated persons with bacteriologically confirmed pulmonary tuberculosis (BC-PTB) have increased risk of developing multi-drug resistant or rifampicin resistant tuberculosis (MDR/RR-TB). Surveillance for resistance is critical to
Externí odkaz:
https://doaj.org/article/ae1e2a35bfb844fe9712f788bb2cc653
Autor:
Tara Catherine Bouton, Audrey Forson, Samuel Kudzawu, Francisca Zigah, Helen Jenkins, Tsigereda Danso Bamfo, Jane Carter, Karen Jacobson, Awewura Kwara
Publikováno v:
The Pan African Medical Journal, Vol 33, Iss 111 (2019)
INTRODUCTION: High mortality among individuals receiving retreatment for tuberculosis (RT-TB) persists, although reasons for these poor outcomes remain unclear. METHODS: We retrospectively reviewed 394 RT-TB patients diagnosed between January 2010 an
Externí odkaz:
https://doaj.org/article/e8589f3cf86b4c37a5f09f69cb500724
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 19, Iss, Pp-(2020)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Rationale Previously treated persons with bacteriologically confirmed pulmonary tuberculosis (BC-PTB) have increased risk of developing multi-drug resistant or rifampicin resistant tuberculosis (MDR/RR-TB). Surveillance for resistance is critical to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c40ea2f40866c9ca6fc6f7fa5244d471
http://www.sciencedirect.com/science/article/pii/S2405579420300115
http://www.sciencedirect.com/science/article/pii/S2405579420300115
Publikováno v:
Tuberkulez i Bolezni Lëgkih, Vol 96, Iss 9, Pp 31-37 (2018)
The article presents the analysis of multiple drug resistant tuberculosis (MDR TB) prevalence among new and previously treated cases in the Kyrgyz Republic in 2016. The part of MDR TB among new cases makes 21.9%, among relapses – 49.2%, and among p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5221afd6be69e8a9fc59efae26279265
https://www.tibl-journal.com/jour/article/view/1174
https://www.tibl-journal.com/jour/article/view/1174
Publikováno v:
The Pan African Medical Journal
Pan African Medical Journal; Vol. 37 No. 1 (2020)
Pan African Medical Journal; Vol. 37 No. 1 (2020)
Introduction:it is unclear what the optimal treatment regimen for previously treated patients with rifampicin-susceptible isoniazid resistant tuberculosis should be. Conflicting evidence exists as to the effectiveness of the WHO standardized category
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5337b47111e06835ce0fe46eb572a3ec
https://doi.org/10.11604/pamj.2020.37.45.25684
https://doi.org/10.11604/pamj.2020.37.45.25684
Autor:
Samuel Kudzawu, Tara C. Bouton, Karen R. Jacobson, Jane Carter, Tsigereda Danso Bamfo, Awewura Kwara, Helen E. Jenkins, Francisca Zigah, Audrey Forson
Publikováno v:
The Pan African Medical Journal
Introduction High mortality among individuals receiving retreatment for tuberculosis (RT-TB) persists, although reasons for these poor outcomes remain unclear. Methods We retrospectively reviewed 394 RT-TB patients diagnosed between January 2010 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ac1ea5a379b9277bc8345f2444e561
https://doi.org/10.11604/pamj.2019.33.111.18574
https://doi.org/10.11604/pamj.2019.33.111.18574
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.